MedPath

The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life

Not Applicable
Recruiting
Conditions
Gynecologic Cancer
Interventions
Behavioral: Education Group
Registration Number
NCT05694208
Lead Sponsor
Istanbul University - Cerrahpasa (IUC)
Brief Summary

This study was planned in a randomized controlled prospective experimental design in order to determine the effect of mobile-based education given to patients undergoing gynecological oncology surgery on quality of life.

Research Hypotheses:

H1. Education given with mobile application in gynecological oncology patients positively affects symptom control of patients.

H2. The education given with the mobile application in gynecological oncology patients positively affects the quality of life of the patients.

Detailed Description

Power analysis was conducted to determine the number of people to be included in the study. The power of the test was calculated with the G\*Power 3.1 program. As a result of the power analysis, the sample size should be 50, 25 experimental and 25 control groups, at 95% power, 5% significance level, and 0.690 effect size (df=24; t=1,710). In the research, it was aimed to reach a total of 70 women, 35 people in each group, considering the high power of the test and the losses.

Introductory Information Form, Symptom Evaluation Form, Functional Assessment of Cancer Therapy-General (FACT-G) and Turkish-Computer System Usability Questionnaire (T-CSUQ- SV) planned to be used as data collection tools in the study.

The women included in the study sample will be divided into two groups as experimental and control groups according to randomization. Experimental group; the group to be trained. control group; This is the group in which no attempt will be made other than data collection.

Statistical Analysis of Data: The data obtained in the research will be analyzed using SPSS (Statistical Package for Social Sciences) for Windows 25.0 program. Homogeneity of descriptive features between groups will be tested by chi-square analysis and independent group t-test. The differentiation status of the scales between the groups will be analyzed with the independent group t-test and the changes within the group will be analyzed with the repeated measures ANOVA test.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • Be over 18 years old
  • Able to speak, read and understand Turkish
  • Being scheduled for surgery due to a diagnosis of gynecological cancer
  • Having internet access
  • Using a smartphone
Exclusion Criteria
  • Having a diagnosis of active psychiatric illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupEducation GroupThe patients in the experimental group will use the mobile-based care support application developed within the scope of the research.
Primary Outcome Measures
NameTimeMethod
The education given with the mobile application in gynecological oncology patients positively affects the quality of life of the patients.Women will be evaluated two weeks after surgery.

The patients' quality of life will be measured with Functional Assessment of Cancer Therapy-General (FACT-G). All questions are aimed at assessing the patients' quality of life in the last 7 days. A higher score from the scale indicates a better quality of life.

Secondary Outcome Measures
NameTimeMethod
Education given with mobile application in gynecological oncology patients positively affects symptom control of patients.Women will be evaluated two weeks after surgery.

The patients' symptom will be measured with Symptom Evaluation Form. The symptom evaluation form was created by the researchers by scanning the relevant literature and determining the most common postoperative symptoms of patients who underwent gynecological oncology surgery.

Trial Locations

Locations (1)

Istanbul University-Cerrahpasa

🇹🇷

Avcılar, İstanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath